ORI.CN
Price:
$0.4
Market Cap:
$11.72M
Orion Nutraceuticals Inc. focuses on the drug for treating asthma and chronic obstructive pulmonary diseases in Canada. The company was formerly known as Cline Capital Corp. Orion Nutraceuticals Inc. was incorporated in 2017 and is headquartered in Vancouver, Canada.
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2018-10-17
Stock Exchange
CNQ
Ticker
ORI.CN
According to Orion Nutraceuticals Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -2.11. This represents a change of -96.09% compared to the average of -53.80 of the last 4 quarters.
The mean historical PE Ratio of Orion Nutraceuticals Inc. over the last ten years is -58.78. The current -2.11 PE Ratio has changed 258.19% with respect to the historical average. Over the past ten years (40 quarters), ORI.CN's PE Ratio was at its highest in in the November 2021 quarter at 2.00K. The PE Ratio was at its lowest in in the February 2018 quarter at -140.72.
Average
-58.78
Median
-8.64
Minimum
-189.63
Maximum
-0.53
Discovering the peaks and valleys of Orion Nutraceuticals Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.67%
Maximum Annual PE Ratio = -0.53
Minimum Annual Increase = -99.68%
Minimum Annual PE Ratio = -189.63
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -189.63 | 352.91% |
| 2023 | -41.87 | 1.67% |
| 2022 | -2.36 | -72.64% |
| 2021 | -8.64 | 257.07% |
| 2020 | -2.42 | 354.99% |
| 2019 | -0.53 | -99.68% |
The current PE Ratio of Orion Nutraceuticals Inc. (ORI.CN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-77.95
5-year avg
-48.98
10-year avg
-58.78
Orion Nutraceuticals Inc.’s PE Ratio is less than CanaFarma Hemp Products Corp. (-0.00), less than Cloud DX Inc. (-1.13), less than RIV Capital Inc. (-0.12), less than Chalice Brands Ltd. (0), less than Khiron Life Sciences Corp. (-0.20), greater than Nass Valley Gateway Ltd. (-3.70), less than VIVO Cannabis Inc. (-0.19), less than EXMceuticals Inc. (-0.81), less than CloudMD Software & Services Inc. (-0.14), less than RYAH Group, Inc. (-0.15),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.00 | $9.78M | |
| -1.13 | $11.68M | |
| -0.12 | $13.70M | |
| 0 | $14.70M | |
| -0.20 | $9.30M | |
| -3.70 | $11.51M | |
| -0.19 | $9.27M | |
| -0.81 | $15.15M | |
| -0.14 | $12.19M | |
| -0.15 | $11.20M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Orion Nutraceuticals Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Orion Nutraceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Orion Nutraceuticals Inc.'s PE Ratio?
How is the PE Ratio calculated for Orion Nutraceuticals Inc. (ORI.CN)?
What is the highest PE Ratio for Orion Nutraceuticals Inc. (ORI.CN)?
What is the 3-year average PE Ratio for Orion Nutraceuticals Inc. (ORI.CN)?
What is the 5-year average PE Ratio for Orion Nutraceuticals Inc. (ORI.CN)?
How does the current PE Ratio for Orion Nutraceuticals Inc. (ORI.CN) compare to its historical average?